Selected EU nations suspend Moderna’s vaccine for young adults

Be the First to Comment Read

Selected EU nations suspend Moderna’s vaccine for young adults

Moderna’s COVID-19 vaccine
Image source: © Ffikretow |


  • Moderna’s COVID-19 vaccine suspended in some counties for younger adults due to some rare side effects.
  • Sweden, Norway, and Denmark paused Moderna’s COVID-19 vaccine and urged younger adults to take Pfizer/BioNTech shot.
  • On 5 October, the European regulator approved the booster shot of Moderna’s COVID-19 vaccine for 12 years or older people.

Few European nations have temporary banned Moderna Inc’s (NASDAQ:MRNA) COVID-19 vaccine in younger adults after appearance of some rare heart related side effects especially after the second shot. Following the suspension news, Moderna’s shares fell as much as 8.94% on 6 October 2021 on NASDAQ.

In January 2021, the European Medicines Agency (EMA) gave green light to Moderna’s COVID-19 vaccine for people 18 years and over. In July, the vaccine was given emergency use authorisation for children aged 12-17 year.   

Scandinavian agencies suspend Moderna’s vaccine

On 6 October 2021, Scandinavian authorities halted administration of COVID-19 vaccine of Moderna in young adults due to an increased risk of inflammation of the heart muscle.  

The Public Health Agency of Sweden had terminated Moderna’s COVID-19 vaccine for those individuals under 30 years. The agency highlighted that the temporary halt would be initially in force until 1 December 2021.

Furthermore, the agency highlighted that, the risk is more prevalent among young men and boys and seems especially related to the second shot of the vaccine.

RELATED ARTICLE: Tips for investing in COVID-19 vaccines developing stocks

Moderna’s COVID-19 vaccine suspended due to side effects

Source: © Ekahardiwito |

Norway and Denmark to continue using Pfizer/BioNTech vaccine

Norway and Denmark also recommended a halt for people under 18 years. Denmark highlighted that the country will continue to use the vaccine developed by Pfizer-BioNTech as its main choice for people aged 12-17 years. Besides, Norway urged people who are under 30 to get the Pfizer-BioNTech’s vaccine instead.

The COVID-19 vaccines developed by Moderna and Pfizer-BioNTech rely on messenger RNA (mRNA) technology to induce an immune reaction against novel coronavirus.

RELATED READ: Role of mRNA vaccines in combating COVID-19: Pros & Cons

Moderna’s booster shot got EMA green light

On 5 October 2021, the European Medicines Agency (EMA) approved the use of a booster shot or third dose of Moderna COVID-19 vaccine for people (12 years of age or older) having severely deteriorated immune system. Moderna highlighted that several studies have demonstrated the benefit of a booster shot of COVID-19 vaccine in people having compromised immune system.

RELATED READ: COVID-19 booster shot for immunocompromised people: are there any additional risks?

EMA approves Moderna’s booster shot

Source: © Demidovichphotostock |

Bottom Line

After witnessing the heart related side effects post administration of Moderna’s COVID-19 vaccine in younger adults, selected European nations have recommended to use Pfizer-BioNTech’s COVID-19 vaccine for adults under 30 year.


Speak your Mind

Featured Articles

kalkine logo


Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK